These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 8176709)

  • 1. 6-Alkyl- and 6-arylandrost-4-ene-3,17-diones as aromatase inhibitors. Synthesis and structure-activity relationships.
    Numazawa M; Oshibe M
    J Med Chem; 1994 Apr; 37(9):1312-9. PubMed ID: 8176709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Further studies on 6-alkylandrost-4-ene-3,17-diones as aromatase inhibitors: elongation of the 6-alkyl chain.
    Numazawa M; Oshibe M
    Steroids; 1995 Aug; 60(8):506-11. PubMed ID: 8539792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 6-Phenylaliphatic-substituted androst-4-ene-3,17-diones as aromatase inhibitors: structure-activity relationships.
    Numazawa M; Yamaguchi S
    J Steroid Biochem Mol Biol; 1998 Oct; 67(1):41-8. PubMed ID: 9780028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and structure-activity relationships of 6-substituted androst-4-ene analogs as aromatase inhibitors.
    Numazawa M; Kamiyama T; Tachibana M; Oshibe M
    J Med Chem; 1996 May; 39(11):2245-52. PubMed ID: 8667367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Probing the binding pocket of the active site of aromatase with 6-ether or 6-ester substituted androst-4-ene-3,17-diones and their diene and triene analogs.
    Numazawa M; Shelangouski M; Nagasaka M
    Steroids; 2000 Dec; 65(12):871-82. PubMed ID: 11077085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time-dependent inactivation of aromatase by 6-alkylandrosta-1,4-diene-3,17-diones. Effects of length and configuration of 6-alkyl group.
    Numazawa M; Oshibe M; Yamaguchi S; Tachibana M
    J Med Chem; 1996 Mar; 39(5):1033-8. PubMed ID: 8676338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 6-Alkylandrosta-4,6-diene-3,17-diones and their 1,4,6-triene analogs as aromatase inhibitors. Structure-activity relationships.
    Numazawa M; Oshibe M; Yamaguchi S
    Steroids; 1997; 62(8-9):595-602. PubMed ID: 9292934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, structure elucidation, and biochemical evaluation of 7 alpha- and 7 beta-arylaliphatic-substituted androst-4-ene-3,17-diones as inhibitors of aromatase.
    O'Reilly JM; Li N; Duax WL; Brueggemeier RW
    J Med Chem; 1995 Jul; 38(15):2842-50. PubMed ID: 7636845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enzymic aromatization of 6-alkyl-substituted androgens, potent competitive and mechanism-based inhibitors of aromatase.
    Numazawa M; Yoshimura A; Oshibe M
    Biochem J; 1998 Jan; 329 ( Pt 1)(Pt 1):151-6. PubMed ID: 9405288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 7-substituted steroidal aromatase inhibitors: structure-activity relationships and molecular modeling.
    Li PK; Brueggemeier RW
    J Enzyme Inhib; 1990; 4(2):113-20. PubMed ID: 2098517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Androst-5-ene-7,17-dione: a novel class of suicide substrate of aromatase.
    Numazawa M; Mutsumi A; Hoshi K; Tanaka Y
    Biochem Biophys Res Commun; 1992 Jul; 186(1):32-9. PubMed ID: 1632774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and structure-activity relationships of 6-phenylaliphatic-substituted C19 steroids having a 1,4-diene, 4,6-diene, or 1,4,6-triene structure as aromatase inhibitors.
    Numazawa M; Yamaguchi S
    Steroids; 1999 Mar; 64(3):187-96. PubMed ID: 10400379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aromatase inhibition by 4-thiosubstituted-4-androstene-3,17-dione derivatives.
    Abul-Hajj YJ
    J Steroid Biochem; 1990 Jan; 35(1):139-43. PubMed ID: 2308324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of human placental aromatase by novel homologated 19-oxiranyl and 19-thiiranyl steroids.
    Childers WE; Silverton JV; Kellis JT; Vickery LE; Robinson CH
    J Med Chem; 1991 Apr; 34(4):1344-9. PubMed ID: 2016709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies directed toward a mechanistic evaluation of aromatase inhibition by androst-5-ene-7,17-dione. Time-dependent inactivation by the 19-nor and 5 beta, 6 beta-epoxy derivatives.
    Numazawa M; Tachibana M
    Steroids; 1997 Jul; 62(7):516-22. PubMed ID: 9253790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and evaluation of 4-substituted-4-androstene-3,17-dione derivatives as aromatase inhibitors.
    Abul-Hajj YJ; Liu XP; Hedge M
    J Steroid Biochem Mol Biol; 1995 Aug; 54(3-4):111-9. PubMed ID: 7662584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Development of aromatase inhibitors and analysis of their inhibitory activities].
    Numazawa M
    Yakugaku Zasshi; 1998 Dec; 118(12):539-53. PubMed ID: 9921263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-activity relationships of 2alpha-substituted androstenedione analogs as aromatase inhibitors and their aromatization reactions.
    Numazawa M; Handa W; Hasegawa C; Takahashi M
    J Steroid Biochem Mol Biol; 2005 Dec; 97(4):353-9. PubMed ID: 16209922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism for aromatase inactivation by a suicide substrate, androst-4-ene-3,6,17-trione. The 4 beta, 5 beta-epoxy-19-oxo derivative as a reactive electrophile irreversibly binding to the active site.
    Numazawa M; Mutsumi A; Tachibana M
    Biochem Pharmacol; 1996 Oct; 52(8):1253-9. PubMed ID: 8937433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological characterization of A-ring steroids.
    Johnston JO; Wright CL; Burkhart JP; Peet NP
    J Steroid Biochem Mol Biol; 1993 Mar; 44(4-6):623-31. PubMed ID: 8476773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.